C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
12/2002
12/24/2002	US6498254 Antiretroviral compounds and compositions
12/24/2002	US6498190 Bicyclic amino derivatives and PGD2 antagonist containing the same
12/24/2002	US6498173 Treatment of diseases based on acute or chronic obstruction of vessels and/or bronchi and/or inflammation
12/24/2002	US6498172 Prostaglandin agonists and their use to treat bone disorders
12/24/2002	US6498162 Treating inflammatory and allergic diseases of respiratory tract and diseases of central nervous system
12/24/2002	US6498125 Pyridine ketones useful as herbicides
12/24/2002	CA2150812C Catechol diethers as selective pde iv inhibitors
12/21/2002	CA2390966A1 Compound for the treatment of atherosclerotic-thrombotic pathological conditions
12/19/2002	WO2002100849A2 Novel nitriles useful as reversible inhibitors of cysteine proteases
12/19/2002	WO2002100846A1 Compounds and methods for the treatment or prevention of flavivirus infections
12/19/2002	WO2002100845A1 Hv protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
12/19/2002	WO2002100844A2 Hiv protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
12/19/2002	WO2002100838A1 2,5-diarylpyrazines, 2,5-diarylpyridines and 2,5-diarylpyrimidines as crf1 receptor modulators
12/19/2002	WO2002100830A1 Pyrrolidine derivatives as factor xa inhibitors
12/19/2002	WO2002100825A2 Anthranilic acid amides with a heteroarylsulfonyl side chain, and use thereof as antiarrhythmic active substances
12/19/2002	WO2002100818A2 Aminediols as agents for the treatment of alzheimer's disease
12/19/2002	WO2002100813A2 Modulators of peroxisome proliferator activated receptors
12/19/2002	WO2002100812A1 Carboxylic acid derivative and salt thereof
12/19/2002	WO2002100410A1 Methods of treating alzheimer's disease
12/19/2002	WO2002100403A1 Modulators of peroxisome proliferator activated receptors (ppar)
12/19/2002	WO2002100400A1 Organic nitrate-based compounds for the treatment of vasculopathies
12/19/2002	WO2002100392A1 Orally administered dosage forms of gaba analog prodrugs having reduced toxicity
12/19/2002	WO2002100368A1 Dyeing composition for keratinous fibres comprising a particular dicationic diazo dye
12/19/2002	WO2002100365A1 Use of dicationic compounds for dyeing human keratinous fibres and compositions containing same
12/19/2002	WO2002100347A2 Prodrugs of gaba analogs, compositions and uses thereof
12/19/2002	WO2002100344A2 Amino acid conjugates providing for sustained systemic concentrations of gaba analogues
12/19/2002	WO2002100341A2 Compounds for the treatment of metabolic disorders
12/19/2002	WO2002080161A3 Optical data carrier that contains a merocyanine dye as the light-absorbing compound in the information layer
12/19/2002	WO2002072544A3 Multifluoro-substituted chalcones and analogs as activators of caspases and inducers of apoptosis and the use thereof
12/19/2002	WO2002070541A3 Peptide deformylase inhibitors
12/19/2002	WO2002059080A3 Trisubstituted carbocyclic cyclophilin binding compounds and their use
12/19/2002	WO2002055501A3 N-pyridyl carboxamide derivatives and pharmaceutical compositions containing them
12/19/2002	US20020193614 Treatment of cardiovascular disorders
12/19/2002	US20020193612 Nicotinamide biaryl derivatives useful as inhibitors of PDE4 isozymes
12/19/2002	US20020193606 Intermediates in manufacture of antibiotic compounds
12/19/2002	US20020193604 Aryl borates
12/19/2002	US20020193596 Inhibitors of protein isoprenyl transferases
12/19/2002	US20020193412 Compounds and compositions for treating tissue ischemia
12/19/2002	US20020193405 For prophylaxis and therapy of diseases, such as cell proliferation or apoptosis mediated diseases
12/19/2002	US20020193398 For therapy and prophylaxis of blood coagulation and cardiovascular disorders
12/19/2002	US20020193388 Pharmaceutically active compounds
12/19/2002	US20020193383 1-(N-phenylalkylaminoalkyl)piperazine derivatives substituted at position 2 of the phenyl ring
12/19/2002	US20020193375 Heterocyclic derivatives which inhibit factor Xa
12/19/2002	US20020193354 7, 9-substituted tetracycline compounds
12/19/2002	US20020190250 Iridium complexes in electron transport layer of Light-emitting diodes; bright, efficient, stable; low temperature vacuum deposition and preventing decomposition
12/19/2002	US20020189033 Substituted 2-aminoalkyl-1,4diaminobenzene compounds and oxidation dye precursor compositions containing same
12/19/2002	DE10128331A1 New 2-(heteroarylsulfonyl-amino)-benzamide derivatives, which are potassium ion channel blocking antiarrhythmic agents, useful for e.g. treating atrial fibrillation or flutter
12/19/2002	DE10121003A1 Anthranilsäureamide, Verfahren zur Herstellung, ihrer Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen Anthranilic acid amides, processes for preparing, their use as a medicament as well as pharmaceutical compositions containing them
12/19/2002	CA2450269A1 Hiv protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
12/19/2002	CA2450265A1 Hiv protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
12/19/2002	CA2450262A1 2,5-diarylpyrazines, 2,5-diarylpyridines and 2,5-diarylpyrimidines as crf1 receptor modulators
12/19/2002	CA2450205A1 Aminediols for the treatment of alzheimer's disease
12/19/2002	CA2449948A1 Methods of treating alzheimer's disease
12/19/2002	CA2449673A1 Orally administered dosage forms of gaba analog prodrugs having reduced toxicity
12/19/2002	CA2449629A1 Pyrrolidine derivatives as factor xa inhibitors
12/19/2002	CA2449256A1 Modulators of peroxisome proliferator activated receptors
12/19/2002	CA2448552A1 Modulators of peroxisome proliferator activated receptors (ppar)
12/18/2002	EP1267369A2 Pyridine compound, its use as charge transfer material, and photoelectrochemical cell
12/18/2002	EP1267170A1 Method for characterising polypeptides
12/18/2002	EP1266660A1 Heme oxygenase-1 inducers or induction enhancers
12/18/2002	EP1265867A1 Novel malonic acid derivates, processes for their preparation, their use as inhibitor of factor xa activity and pharmaceutical compositions containing them
12/18/2002	EP1265866A2 Aryl substituted pyridines, pyrimidines, pyrazines and triazines and the use thereof
12/18/2002	EP1265865A2 Difluorobutyric acid derivatives and their use as metalloprotease inhibitors
12/18/2002	EP1265861A2 Benzylated pde4 inhibitors
12/18/2002	EP1265855A1 Novel cd23 inhibitors
12/18/2002	EP1265850A2 Insecticidal anthranilamides
12/18/2002	EP1265848A2 Amines substituted with a dihydronaphthalenyl, crhomenyl, or thiochromenyl group, an aryl or heteroaryl group and an alkyl group, having retinoid-like biological activity
12/18/2002	EP1265606A1 Cell adhesion inhibitors
12/18/2002	EP1140847B1 Substituted 2-phenylpyridines as herbicides
12/18/2002	EP1102777B1 Preparation of polymerisation catalysts
12/18/2002	EP0934300B1 The preparation and use of ortho-sulfonamido heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors
12/18/2002	EP0843658B1 Didepsipeptide-based endoparasiticides, new didepsipeptides and process for preparing the same
12/18/2002	EP0778844B1 Functional terpyridine metal complexes, methods for their preparation and oligonucleotide conjugates with terpyridine metal complexes
12/18/2002	CN1386132A Antimicrobial composition
12/18/2002	CN1385429A High-tension condensed ring nicotine analogue, preparation process and use thereof
12/18/2002	CN1096446C N-(ortho-substd-benzyloxy)imine derivs, and their use as fungicides, acaricides or insecticides
12/17/2002	US6495695 Process for the preparation of a collidine and 2,3,5,6-tetramethyl pyridine
12/17/2002	US6495686 Therapy for psychological disorders
12/17/2002	US6495685 Process for preparing piperazine derivatives
12/17/2002	US6495607 Benzocycloheptenes, process for their production, pharmaceutical preparations that contain the latter as well as their use for the production of pharmaceutical agents
12/17/2002	US6495581 Drug for treating diabetes mellitus, hyperlipemia, impaired glucose tolerance, arterial sclerosis and improving insulin resistance, inflammatory disease
12/17/2002	US6495576 N-(1-((3,4-dioxo-2-(3-pyridinylamino)-1-cyclobuten-1-yl)amino) -2,2-dimethylpropyl)-4-methylbenzamide for example; treating bladder overactivity, benign prostatic hyperplasia, premature labor, and sexual disorders
12/17/2002	US6495573 Non-systemic control of parasites
12/17/2002	US6495571 Administering to the mammal an effective cancer treatment amount of the compound 3,5-dichloro-4,6-diethoxy-2-(trichloromethyl)pyridine or and acid addition salt to treat the cancer
12/17/2002	US6495550 Substituted benzamido-pyridine derivatives for treatment of disorders mediated by potassium channels
12/17/2002	US6495546 Propanolamine derivatives
12/17/2002	CA2053803C Process for the preparation of (3-fluoropyridin-2-yloxy)phenoxypropionic acids
12/12/2002	WO2002099124A2 Characterising polypeptides
12/12/2002	WO2002098956A1 Monomers having rotaxane structure and polymers and processes for production of both
12/12/2002	WO2002098869A2 1,4-disubstituted benzo-fused cycloalkyl urea compounds
12/12/2002	WO2002098858A1 Integrin antagonists
12/12/2002	WO2002098854A2 Process for preparing chiral diol sulfones and dihydroxy acid hmg coa reductase inhibitors
12/12/2002	WO2002098849A2 Hydroxy alkyl amine derivatives as beta-secretase inhibitors and their use for the treatment of alzheimer’s disease and similar diseases
12/12/2002	WO2002098848A1 Benzoylsulfonamides and sulfonylbenzamidines for use as antitumour agents
12/12/2002	WO2002098840A1 Carboxylic acid derivative and medicine comprising salt or ester of the same
12/12/2002	WO2002098420A1 4-substituted-1-(arylmethylidene)thiosemicarbazide, 4-substituted-1-(arylcarbonyl)thiosemicarbazide and analogs as activators of caspases and inducers of apoptosis and the use thereof
12/12/2002	WO2002098406A1 Novel compounds and compositions as cathepsin inhibitors
12/12/2002	WO2002064080A3 Matrix metalloproteinase inhibitors
12/12/2002	US20020188130 Alpha, alpha-dibromo-alpha-chloro-acetophenones as synthons
12/12/2002	US20020188124 Novel spiro compounds

1 ... 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 ... 633